Indefinite Delivery Contract SPE2DP26D0005

Seqirus USA Inc. has been awarded a single-award Indefinite Delivery Contract valued at $2.26 million by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency, with an award date of February 4, 2026, and an ultimate completion date of February 3, 2027. This contract does not utilize any set-aside designations and represents the prime contractor's continued engagement with the federal government to supply injectable influenza vaccines for the 2026-2027 flu season. The Defense Logistics Agency Troop Support Medical sought contractors capable of delivering approximately 3.08 million doses of FDA-approved, prefilled syringe formulations of influenza vaccine suitable for multiple age categories, including individuals 65 years and older, 18 years and older, 3 years and older, and pediatric populations aged 6 months to 35 months. All deliveries are required to the Defense Depot in New Cumberland, Pennsylvania, following a staggered schedule with 40 percent due by August 14, 2026, 25 percent by August 28, 2026, 25 percent by September 11, 2026, and the remaining 10 percent by September 25, 2026.

The contract guarantees a minimum purchase quantity of 75 percent of the annual estimate, approximately 2.31 million doses, with a maximum ceiling of 150 percent of the annual estimate, representing approximately 4.62 million doses. All supplied vaccines must possess FDA approval and comply with recommendations from the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, with specific formulations to be determined by the FDA Vaccines and Related Biological Products Advisory Committee. This procurement falls under NAICS code 325414 for Biological Product Manufacturing and Federal Supply Schedule code 6505 for Drugs and Biologicals. Seqirus USA Inc., headquartered in Summit, New Jersey, is an established federal contractor since 2008 with extensive experience delivering influenza vaccines across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Bureau of Prisons, and Centers for Disease Control and Prevention, positioning the company as a critical supplier within the federal medical supply chain.